Given the excellent specificity of the persistently positive DGP-IgG assay in our study (100%), and in addition to its ability to identify a single CeD patient with total IgA deficiency, it could be used in combination with TTG-IgA test in initial screening of general population without the need to measure total IgA. This evidence concerns the gene CD79A and selective IgA deficiency disease.